Inhibition of microglial inflammation by the MLK inhibitor CEP-1347

Lade...
Vorschaubild
Datum
2005
Autor:innen
Lund, Søren
Porzgen, Peter
Mortensen, Anna-Louise
Hasseldam, Henrik
Bozyczko-Coyne, Donna
Morath, Siegfried
Bianchi, Marina
Ghezzi, Pietro
Bsibsi, Malika
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Journal of Neurochemistry. 2005, 92(6), pp. 1439-1451. ISSN 0022-3042. eISSN 1471-4159. Available under: doi: 10.1111/j.1471-4159.2005.03014.x
Zusammenfassung

CEP-1347 is a potent inhibitor of the mixed lineage kinases (MLKs), a distinct family of mitogen-activated protein kinase kinase kinases (MAPKKK). It blocks the activation of the c-Jun/JNK apoptotic pathway in neurons exposed to various stressors and attenuates neurodegeneration in animal models of Parkinson's disease (PD). Microglial activation may involve kinase pathways controlled by MLKs and might contribute to the pathology of neurodegenerative diseases. Therefore, the possibility that CEP-1347 modulates the microglial inflammatory response [tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1)] was explored. Indeed, the MLK inhibitor CEP-1347 reduced cytokine production in primary cultures of human and murine microglia, and in monocyte/macrophage-derived cell lines, stimulated with various endotoxins or the plaque forming peptide Aβ1 40. Moreover, CEP-1347 inhibited brain TNF production induced by intracerebroventricular injection of lipopolysaccharide in mice. As expected from a MLK inhibitor, CEP-1347 acted upstream of p38 and c-Jun activation in microglia by dampening the activity of both pathways. These data imply MLKs as important, yet unrecognized, modulators of microglial inflammation, and demonstrate a novel anti-inflammatory potential of CEP-1347.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Alzheimer s disease, central nervous system, mixed lineage kinase, CEP-1347, inflammation, microglia, TNF-alpha
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690LUND, Søren, Peter PORZGEN, Anna-Louise MORTENSEN, Henrik HASSELDAM, Donna BOZYCZKO-COYNE, Siegfried MORATH, Thomas HARTUNG, Marina BIANCHI, Pietro GHEZZI, Malika BSIBSI, Sipke DIJKSTRA, Marcel LEIST, 2005. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347. In: Journal of Neurochemistry. 2005, 92(6), pp. 1439-1451. ISSN 0022-3042. eISSN 1471-4159. Available under: doi: 10.1111/j.1471-4159.2005.03014.x
BibTex
@article{Lund2005Inhib-8000,
  year={2005},
  doi={10.1111/j.1471-4159.2005.03014.x},
  title={Inhibition of microglial inflammation by the MLK inhibitor CEP-1347},
  number={6},
  volume={92},
  issn={0022-3042},
  journal={Journal of Neurochemistry},
  pages={1439--1451},
  author={Lund, Søren and Porzgen, Peter and Mortensen, Anna-Louise and Hasseldam, Henrik and Bozyczko-Coyne, Donna and Morath, Siegfried and Hartung, Thomas and Bianchi, Marina and Ghezzi, Pietro and Bsibsi, Malika and Dijkstra, Sipke and Leist, Marcel}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/8000">
    <dc:creator>Bozyczko-Coyne, Donna</dc:creator>
    <dc:creator>Hasseldam, Henrik</dc:creator>
    <dc:contributor>Bozyczko-Coyne, Donna</dc:contributor>
    <dc:creator>Ghezzi, Pietro</dc:creator>
    <dc:contributor>Hartung, Thomas</dc:contributor>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dc:contributor>Ghezzi, Pietro</dc:contributor>
    <dc:contributor>Lund, Søren</dc:contributor>
    <dc:contributor>Morath, Siegfried</dc:contributor>
    <dc:contributor>Bsibsi, Malika</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Mortensen, Anna-Louise</dc:contributor>
    <dcterms:bibliographicCitation>First publ. in: Journal of Neurochemistry 92 (2005), 6, pp. 1439-1451</dcterms:bibliographicCitation>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8000/1/Inhibition_of_microglial_inflammation_by_the_MLK_inhibitor.pdf"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/8000"/>
    <dc:contributor>Porzgen, Peter</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/8000/1/Inhibition_of_microglial_inflammation_by_the_MLK_inhibitor.pdf"/>
    <dc:creator>Hartung, Thomas</dc:creator>
    <dcterms:abstract xml:lang="eng">CEP-1347 is a potent inhibitor of the mixed lineage kinases (MLKs), a distinct family of mitogen-activated protein kinase kinase kinases (MAPKKK). It blocks the activation of the c-Jun/JNK apoptotic pathway in neurons exposed to various stressors and attenuates neurodegeneration in animal models of Parkinson's disease (PD). Microglial activation may involve kinase pathways controlled by MLKs and might contribute to the pathology of neurodegenerative diseases. Therefore, the possibility that CEP-1347 modulates the microglial inflammatory response [tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and monocyte chemotactic protein-1 (MCP-1)] was explored. Indeed, the MLK inhibitor CEP-1347 reduced cytokine production in primary cultures of human and murine microglia, and in monocyte/macrophage-derived cell lines, stimulated with various endotoxins or the plaque forming peptide Aβ1 40. Moreover, CEP-1347 inhibited brain TNF production induced by intracerebroventricular injection of lipopolysaccharide in mice. As expected from a MLK inhibitor, CEP-1347 acted upstream of p38 and c-Jun activation in microglia by dampening the activity of both pathways. These data imply MLKs as important, yet unrecognized, modulators of microglial inflammation, and demonstrate a novel anti-inflammatory potential of CEP-1347.</dcterms:abstract>
    <dc:contributor>Hasseldam, Henrik</dc:contributor>
    <dc:contributor>Bianchi, Marina</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:39:11Z</dc:date>
    <dc:creator>Porzgen, Peter</dc:creator>
    <dc:format>application/pdf</dc:format>
    <dcterms:issued>2005</dcterms:issued>
    <dc:language>eng</dc:language>
    <dc:creator>Mortensen, Anna-Louise</dc:creator>
    <dc:creator>Dijkstra, Sipke</dc:creator>
    <dc:creator>Bsibsi, Malika</dc:creator>
    <dc:creator>Morath, Siegfried</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <dc:creator>Bianchi, Marina</dc:creator>
    <dc:contributor>Dijkstra, Sipke</dc:contributor>
    <dc:creator>Leist, Marcel</dc:creator>
    <dc:creator>Lund, Søren</dc:creator>
    <dcterms:title>Inhibition of microglial inflammation by the MLK inhibitor CEP-1347</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:39:11Z</dcterms:available>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen